PTEN and urinary bladder carcinoma: However, activated PPARγ also inhibits angiogenesis by suppressing the PI3K/AKT pathway (Figure 4) similarly to the phosphatase and tensin homolog (PTEN) as was shown in model of bladder cancer chemotherapy [147].